Last reviewed · How we verify
Daily FSH and GnRH antagonist
Daily FSH and GnRH antagonist is a Small molecule drug developed by Bioroma. It is currently FDA-approved.
At a glance
| Generic name | Daily FSH and GnRH antagonist |
|---|---|
| Sponsor | Bioroma |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study) (NA)
- A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA) (PHASE3)
- IVF Outcomes With Time-Lapse Culture: Comparison Between PPOS and GnRH Antagonist Protocols (NA)
- Ovarian Hyperstimulation and Fibrin Clot Properties. (NA)
- NATural Ovarian Stimulation (PHASE4)
- An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation (PHASE1)
- Is the Diurnal Variation in Circulating Levels of Cortisol Reflected in Follicular Fluid of Preovulatory Follicles Close to Ovulation?
- An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Daily FSH and GnRH antagonist CI brief — competitive landscape report
- Daily FSH and GnRH antagonist updates RSS · CI watch RSS
- Bioroma portfolio CI
Frequently asked questions about Daily FSH and GnRH antagonist
What is Daily FSH and GnRH antagonist?
Daily FSH and GnRH antagonist is a Small molecule drug developed by Bioroma.
Who makes Daily FSH and GnRH antagonist?
Daily FSH and GnRH antagonist is developed and marketed by Bioroma (see full Bioroma pipeline at /company/bioroma).
What development phase is Daily FSH and GnRH antagonist in?
Daily FSH and GnRH antagonist is FDA-approved (marketed).
Related
- Manufacturer: Bioroma — full pipeline
- Compare: Daily FSH and GnRH antagonist vs similar drugs
- Pricing: Daily FSH and GnRH antagonist cost, discount & access